Cargando…

Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study

OBJECTIVE: We aimed to investigate which clinical and metabolic tests offer optimal accuracy and acceptability to help diagnose diabetes among a large sample of people with serious mental illness in receipt of antipsychotic medication. METHODS: A prospective observational study design of biochemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Alex J., Vancampfort, Davy, Manu, Peter, Correll, Christoph U., Wampers, Martien, van Winkel, Ruud, Yu, Weiping, De Hert, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742458/ https://www.ncbi.nlm.nih.gov/pubmed/31513598 http://dx.doi.org/10.1371/journal.pone.0210674

Ejemplares similares

Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness
por: Mazereel, Victor, et al.
Publicado: (2020)

A quantitative assessment of the views of mental health professionals on exercise for people with mental illness: perspectives from a low-resource setting
por: Vancampfort, Davy, et al.
Publicado: (2019)

Attitudes of Psychiatric Nurses about the Request for Euthanasia on the Basis of Unbearable Mental Suffering(UMS)
por: De Hert, Marc, et al.
Publicado: (2015)

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study
por: De Hert, Marc, et al.
Publicado: (2011)

Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis
por: Bernagie, Chiara, et al.
Publicado: (2016)

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study
por: De Hert, M, et al.
Publicado: (2006)

The Role of Working Memory in the Processing of Scalar Implicatures of Patients With Schizophrenia Spectrum and Other Psychotic Disorders
por: Schaeken, Walter, et al.
Publicado: (2021)

The intriguing relationship between coronary heart disease and mental disorders
por: De Hert, Marc, et al.
Publicado: (2018)

Physical activity participation is associated with higher quality of life scores in men with alcohol use disorders: a study from Uganda
por: Vancampfort, Davy, et al.
Publicado: (2020)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Barriers, attitudes, confidence, and knowledge of nurses regarding metabolic health screening and intervention in people with mental illness: a pilot study from Uganda
por: Vancampfort, Davy, et al.
Publicado: (2019)

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
por: Llorca, Pierre Michel, et al.
Publicado: (2013)

Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review
por: Mugisha, James, et al.
Publicado: (2017)

Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
por: Younas, Mediha, et al.
Publicado: (2016)

Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice
por: Jakobs, Kirsti M., et al.
Publicado: (2020)

A Clinical Review of the Treatment of Catatonia
por: Sienaert, Pascal, et al.
Publicado: (2014)

Risk of Hospitalized Falls and Hip Fractures in 22,103 Older Adults Receiving Mental Health Care vs 161,603 Controls: A Large Cohort Study
por: Stubbs, Brendon, et al.
Publicado: (2020)

WHICH PATIENTS SHOULD RECEIVE RADIOTHERAPY IN POSTOPERATIVE DISEASE RECURRENCE?
por: Matić, Mate, et al.
Publicado: (2019)

Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness
por: Forma, Felicia, et al.
Publicado: (2020)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness
por: Valenstein, Marcia, et al.
Publicado: (2011)

Which patients with heart failure should receive specialist palliative care?
por: Campbell, Ross T., et al.
Publicado: (2018)

O.4.2-1 The within-person bidirectional association between physical activity and loneliness in the daily lives of adolescents and young adults
por: Jennen, Lise, et al.
Publicado: (2023)

Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?
por: Mc Namara, Kevin P, et al.
Publicado: (2022)

Management of serious cardiac adverse effects of antipsychotic medications
por: Stoner, Steven C.
Publicado: (2018)

Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes
por: Aakre, Jennifer M, et al.
Publicado: (2012)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Pharmacological treatment of ambulatory schizophrenic patients in Belgium
por: Hanssens, L, et al.
Publicado: (2006)

Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice
por: Egberts, Karin M., et al.
Publicado: (2022)

Clinical predictors of therapeutic response to antipsychotics in schizophrenia
por: Carbon, Maren, et al.
Publicado: (2014)

Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data
por: Stockbridge, Erica L., et al.
Publicado: (2021)

The meaning of being a visiting child of a seriously ill parent receiving care at the ICU
por: Knutsson, Susanne, et al.
Publicado: (2021)

T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA
por: Galling, Britta, et al.
Publicado: (2018)

Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database
por: Kimura, Goji, et al.
Publicado: (2015)

Ischemic colitis related to antipsychotics : A rare and serious entity to know
por: Moalla, M., et al.
Publicado: (2022)

An impaired health related muscular fitness contributes to a reduced walking capacity in patients with schizophrenia: a cross-sectional study
por: Vancampfort, Davy, et al.
Publicado: (2013)

Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?
por: Ilyas, Athif, et al.
Publicado: (2017)

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
por: Velligan, Dawn I, et al.
Publicado: (2017)

The Use of Long-Acting Injectable Antipsychotics (LAI) in the Serious Mental Illness (SMI) Patients Enrolled in an Assertive Community Treatment (ACT) Program
por: Yee, Maria Ruiza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f9to3mfp7tjoutu4l97l9neph8